India News | Press Trust of India | Thursday November 26, 2020
Phase-three of human clinical trial of the India-made COVID-19 vaccine candidate Covaxin began at AIIMS in Delhi on Thursday with Dr MV Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
www.ndtv.com